| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3014490 | Revista Española de Cardiología | 2009 | 4 Pages | 
Abstract
												Genetic studies can play a key role in the comprehensive evaluation of familiar hypertrophic cardiomyopathy and in the development of individualized medicine. Although only a few cases have been described, there exists a group of patients with complex genotypes that are associated with severe disease manifestations and a high risk of sudden death. We describe a family in which some members experienced the early development of systolic and diastolic dysfunction while others experienced sudden death at a young age. We identified a novel homozygous mutation (IVS6+5G>A) in the myosin-binding protein-C gene that explained the phenotype of affected individuals and that enabled us to estimate the risk in other family members and to offer genetic counseling.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												MartÃn F. Ortiz, MarÃa Isabel RodrÃguez-GarcÃa, Manuel Hermida-Prieto, Xusto Fernández, Elena Veira, Roberto Barriales-Villa, Alfonso Castro-Beiras, Lorenzo Monserrat, 
											